| Net Cash Provided by (Used in) Operating Activities |
$12,340 |
USD |
90% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$740 |
USD |
-67% |
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$26,860 |
USD |
-5326% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
129,117,273 |
shares |
2.4% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$12,340 |
USD |
92% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,691,713 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2024 |
| Depreciation |
$0 |
USD |
-100% |
Q2 2024 |
Q2 2024 |
| Property, Plant and Equipment, Gross |
$22,285 |
USD |
0% |
Q2 2024 |
Q2 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,691,713 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5,000,350 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$10,573,582 |
USD |
0.26% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$3,542 |
USD |
556% |
Q1 2024 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |